Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2024 Mar 28

PMID 38540111

Authors

Jan Traub

Martin S Weber

Anna Frey

Affiliations

Soon will be listed here.

Abstract

Factor XIII is a transglutaminase enzyme that plays a crucial role in hemostasis and wound healing. It crosslinks fibrin strands, stabilizing clots and promoting clot resistance to fibrinolysis. Additionally, Factor XIII has been found to have multiple other functions that extend beyond coagulation, including the regulation of inflammation and tissue repair processes. Emerging evidence suggests that Factor XIII may also have differential roles in acute myocardial infarction and ischemic stroke, two common cardiovascular events with significant morbidity and mortality. In acute myocardial infarction, Factor XIII has been implicated in promoting clot stability and reducing the risk of re-occlusion. In ischemic stroke, Factor XIII may also contribute to the pathogenesis of cerebral ischemia by promoting clot formation and exacerbating neuronal damage. Several studies have investigated the association between Factor XIII and these cardiovascular events, using various approaches such as genetic polymorphism analysis, animal models, and clinical data analysis. These studies have provided important insights into the role of Factor XIII in acute myocardial infarction and ischemic stroke, highlighting its potential as a therapeutic target for interventions aimed at improving outcomes in these conditions. In this review, we will summarize the current understanding of Factor XIII's role in acute myocardial infarction and ischemic stroke.

References

Griffin M, Casadio R, Bergamini C . Transglutaminases: nature's biological glues. Biochem J. 2002; 368(Pt 2):377-96. PMC: 1223021. DOI: 10.1042/BJ20021234. View

Inbal A, Lubetsky A, Krapp T, Castel D, Shaish A, Dickneitte G . Impaired wound healing in factor XIII deficient mice. Thromb Haemost. 2005; 94(2):432-7. DOI: 10.1160/TH05-04-0291. View

Duque P, Chasco-Ganuza M, Ortuzar A, Almaraz C, Terradillos E, Perez-Rus G . Acquired FXIII Deficiency is Associated with High Morbidity. Thromb Haemost. 2021; 122(1):48-56. DOI: 10.1055/a-1481-2733. View

Chen J, Figueiredo J, Wojtkiewicz G, Siegel C, Iwamoto Y, Kim D . Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway. JACC Cardiovasc Imaging. 2012; 5(11):1127-38. PMC: 3502014. DOI: 10.1016/j.jcmg.2012.01.025. View

Doggen C, Reiner A, Vos H, Rosendaal F . Two factor XIII gene polymorphisms associated with a structural and functional defect and the risk of myocardial infarction in men. J Thromb Haemost. 2003; 1(9):2056-8. DOI: 10.1046/j.1538-7836.2003.00352.x. View

Murphy A, Goldberg S . Mechanical Complications of Myocardial Infarction. Am J Med. 2022; 135(12):1401-1409. DOI: 10.1016/j.amjmed.2022.08.017. View

Sun X, Berthiller J, Derex L, Trouillas P, Diallo L, Hanss M . Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome. J Neurol Sci. 2015; 349(1-2):77-83. DOI: 10.1016/j.jns.2014.12.029. View

Gemmati D, Federici F, Campo G, Tognazzo S, Serino M, De Mattei M . Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. Mol Med. 2007; 13(1-2):112-20. PMC: 1869629. DOI: 10.2119/2006-00049.Gemmati. View

Biswas A, Ivaskevicius V, Thomas A, Oldenburg J . Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms. Hamostaseologie. 2014; 34(2):160-6. DOI: 10.5482/HAMO-13-08-0046. View

10.

Kreutz R, Schmeisser G, Schaffter A, Kanuri S, Owens J, Maatman B . Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity. TH Open. 2019; 2(2):e173-e181. PMC: 6419750. DOI: 10.1055/s-0038-1645876. View

11.

Salomi B, Solomon R, Turaka V, Aaron S, Christudass C . Cryptogenic Stroke in the Young: Role of Candidate Gene Polymorphisms in Indian Patients with Ischemic Etiology. Neurol India. 2022; 69(6):1655-1662. DOI: 10.4103/0028-3886.333441. View

12.

Kreutz R, Bitar A, Owens J, Desta Z, Breall J, von der Lohe E . Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease. J Thromb Thrombolysis. 2014; 38(3):380-7. PMC: 4295494. DOI: 10.1007/s11239-014-1059-4. View

13.

Bereczky Z, Balogh E, Katona E, Czuriga I, Edes I, Muszbek L . Elevated factor XIII level and the risk of myocardial infarction in women. Haematologica. 2007; 92(2):287-8. DOI: 10.3324/haematol.10647. View

14.

Muszbek L, Haramura G, Polgar J . Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets. Thromb Haemost. 1995; 73(4):702-5. View

15.

Shemirani A, Pongracz E, Antalfi B, Adany R, Muszbek L . Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke. Thromb Res. 2010; 126(2):159-62. DOI: 10.1016/j.thromres.2010.06.012. View

16.

Jaffer F, Sosnovik D, Nahrendorf M, Weissleder R . Molecular imaging of myocardial infarction. J Mol Cell Cardiol. 2006; 41(6):921-33. DOI: 10.1016/j.yjmcc.2006.09.008. View

17.

Epstein F . MR in mouse models of cardiac disease. NMR Biomed. 2007; 20(3):238-55. DOI: 10.1002/nbm.1152. View

18.

Komaromi I, Bagoly Z, Muszbek L . Factor XIII: novel structural and functional aspects. J Thromb Haemost. 2010; 9(1):9-20. DOI: 10.1111/j.1538-7836.2010.04070.x. View

19.

Sarecka-Hujar B, Kopyta I, Skrzypek M . Lack of Associations Between and Polymorphisms and Arterial Ischemic Stroke in Children: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost. 2019; 25:1076029619869500. PMC: 6829646. DOI: 10.1177/1076029619869500. View

20.

Ivaskevicius V, Seitz R, Kohler H, Schroeder V, Muszbek L, Ariens R . International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost. 2007; 97(6):914-21. View